Trial
NCT04540393
AZD1222 Vaccine for the Prevention of COVID-19
Phase IIIWITHDRAWNSAFETYConfidence: HIGH
Sponsor
AstraZeneca
Collaborators
IQVIA Pty Ltd; Covance
Condition
COVID-19
Intervention
AZD1222
Why stopped
The study was put on hold in September 2020 due to a safety concern in another trial but never restarted. In the meantime our clinical development program now includes a similar study with a different design, which we prefer to complete now.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-01